Global Site-directed Mutagenesis Service Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Site-directed Mutagenesis Service market size was valued at USD 1002.2 million in 2022 and is forecast to a readjusted size of USD 1372.4 million by 2029 with a CAGR of 4.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Site-directed mutagenesis is a widely used technique in molecular biology and genetic engineering that allows researchers to introduce specific changes or mutations into a DNA sequence.
Site-directed mutagenesis services are provided by various companies and research institutions to support scientific research, drug development, and other applications requiring precise modifications to DNA sequences. These services often involve the design and synthesis of custom DNA templates with specific mutations or modifications requested by the client.
The market status and future development trends of the site-directed mutagenesis service market include the following:
Increasing Demand: With advancements in genetic research and biotechnology applications, there is a growing demand for site-directed mutagenesis services. Researchers in academia, pharmaceutical companies, and biotech firms rely on these services to create specific genetic variants for functional studies, protein engineering, therapeutic development, and other research purposes.
Customization and Specialization: As the field of genetics becomes more specialized, site-directed mutagenesis service providers may focus on offering tailored solutions to meet the specific needs of different research areas or industries. This could involve expertise in specific organisms, gene families, or targeted genetic modifications.
Automation and High-throughput Capabilities: To improve efficiency and cost-effectiveness, site-directed mutagenesis services may adopt automation and high-throughput technologies. This allows for the simultaneous generation of multiple mutations or modifications in a faster and more streamlined manner.
Quality Assurance and Validation: Given the critical nature of site-directed mutagenesis in research and product development, there is an increasing emphasis on quality control, validation, and rigorous quality assurance measures by service providers. This ensures accurate and reliable results, which are essential for downstream applications.
Integration with Other Services: Site-directed mutagenesis services may be integrated with other molecular biology services or techniques to offer comprehensive solutions. For example, providers may offer sequencing, gene synthesis, or cloning services alongside site-directed mutagenesis to facilitate a seamless workflow for researchers.
Regulatory Compliance: As the applications of site-directed mutagenesis expand into areas like gene therapy or agricultural biotechnology, adherence to regulatory guidelines and ethical considerations will become increasingly important.
This report is a detailed and comprehensive analysis for global Site-directed Mutagenesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Site-directed Mutagenesis Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Site-directed Mutagenesis Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Site-directed Mutagenesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Site-directed Mutagenesis Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Site-directed Mutagenesis Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Site-directed Mutagenesis Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript, Eurofins, Applied Biological Materials, Azenta Life Sciences and Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Site-directed Mutagenesis Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Site-directed Mutagenesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Site-directed Mutagenesis Service, with revenue, gross margin and global market share of Site-directed Mutagenesis Service from 2018 to 2023.
Chapter 3, the Site-directed Mutagenesis Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Site-directed Mutagenesis Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Site-directed Mutagenesis Service.
Chapter 13, to describe Site-directed Mutagenesis Service research findings and conclusion.
Site-directed mutagenesis is a widely used technique in molecular biology and genetic engineering that allows researchers to introduce specific changes or mutations into a DNA sequence.
Site-directed mutagenesis services are provided by various companies and research institutions to support scientific research, drug development, and other applications requiring precise modifications to DNA sequences. These services often involve the design and synthesis of custom DNA templates with specific mutations or modifications requested by the client.
The market status and future development trends of the site-directed mutagenesis service market include the following:
Increasing Demand: With advancements in genetic research and biotechnology applications, there is a growing demand for site-directed mutagenesis services. Researchers in academia, pharmaceutical companies, and biotech firms rely on these services to create specific genetic variants for functional studies, protein engineering, therapeutic development, and other research purposes.
Customization and Specialization: As the field of genetics becomes more specialized, site-directed mutagenesis service providers may focus on offering tailored solutions to meet the specific needs of different research areas or industries. This could involve expertise in specific organisms, gene families, or targeted genetic modifications.
Automation and High-throughput Capabilities: To improve efficiency and cost-effectiveness, site-directed mutagenesis services may adopt automation and high-throughput technologies. This allows for the simultaneous generation of multiple mutations or modifications in a faster and more streamlined manner.
Quality Assurance and Validation: Given the critical nature of site-directed mutagenesis in research and product development, there is an increasing emphasis on quality control, validation, and rigorous quality assurance measures by service providers. This ensures accurate and reliable results, which are essential for downstream applications.
Integration with Other Services: Site-directed mutagenesis services may be integrated with other molecular biology services or techniques to offer comprehensive solutions. For example, providers may offer sequencing, gene synthesis, or cloning services alongside site-directed mutagenesis to facilitate a seamless workflow for researchers.
Regulatory Compliance: As the applications of site-directed mutagenesis expand into areas like gene therapy or agricultural biotechnology, adherence to regulatory guidelines and ethical considerations will become increasingly important.
This report is a detailed and comprehensive analysis for global Site-directed Mutagenesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Site-directed Mutagenesis Service market size and forecasts, in consumption value ($ Million), 2018-2029
Global Site-directed Mutagenesis Service market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Site-directed Mutagenesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Site-directed Mutagenesis Service market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Site-directed Mutagenesis Service
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Site-directed Mutagenesis Service market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GenScript, Eurofins, Applied Biological Materials, Azenta Life Sciences and Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Site-directed Mutagenesis Service market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Standard Site-directed Mutagenesis Service
- Customized Site-directed Mutagenesis Service
- Scientific Research
- Gene Therapy
- Cell Therapy
- Others
- GenScript
- Eurofins
- Applied Biological Materials
- Azenta Life Sciences
- Thermo Fisher Scientific
- Bon Opus Biosciences
- Charles Rive
- Creative Biogene
- Synbio Technologies
- Creative Biolabs
- NovoPro
- Bionexus
- Biotech Desk
- NorClone
- Eton Bioscience
- Syd Labs
- Genosphere Biotechnologies
- WZ Biosciences
- FulenGen
- GENEWIZ
- iGene Biotechnology
- Tsingke
- AtaGenix
- Zoonbio Biotechnology
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Site-directed Mutagenesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Site-directed Mutagenesis Service, with revenue, gross margin and global market share of Site-directed Mutagenesis Service from 2018 to 2023.
Chapter 3, the Site-directed Mutagenesis Service competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Site-directed Mutagenesis Service market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Site-directed Mutagenesis Service.
Chapter 13, to describe Site-directed Mutagenesis Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Site-directed Mutagenesis Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Site-directed Mutagenesis Service by Type
1.3.1 Overview: Global Site-directed Mutagenesis Service Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Site-directed Mutagenesis Service Consumption Value Market Share by Type in 2022
1.3.3 Standard Site-directed Mutagenesis Service
1.3.4 Customized Site-directed Mutagenesis Service
1.4 Global Site-directed Mutagenesis Service Market by Application
1.4.1 Overview: Global Site-directed Mutagenesis Service Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Scientific Research
1.4.3 Gene Therapy
1.4.4 Cell Therapy
1.4.5 Others
1.5 Global Site-directed Mutagenesis Service Market Size & Forecast
1.6 Global Site-directed Mutagenesis Service Market Size and Forecast by Region
1.6.1 Global Site-directed Mutagenesis Service Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Site-directed Mutagenesis Service Market Size by Region, (2018-2029)
1.6.3 North America Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.4 Europe Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.6 South America Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 GenScript
2.1.1 GenScript Details
2.1.2 GenScript Major Business
2.1.3 GenScript Site-directed Mutagenesis Service Product and Solutions
2.1.4 GenScript Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GenScript Recent Developments and Future Plans
2.2 Eurofins
2.2.1 Eurofins Details
2.2.2 Eurofins Major Business
2.2.3 Eurofins Site-directed Mutagenesis Service Product and Solutions
2.2.4 Eurofins Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eurofins Recent Developments and Future Plans
2.3 Applied Biological Materials
2.3.1 Applied Biological Materials Details
2.3.2 Applied Biological Materials Major Business
2.3.3 Applied Biological Materials Site-directed Mutagenesis Service Product and Solutions
2.3.4 Applied Biological Materials Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Applied Biological Materials Recent Developments and Future Plans
2.4 Azenta Life Sciences
2.4.1 Azenta Life Sciences Details
2.4.2 Azenta Life Sciences Major Business
2.4.3 Azenta Life Sciences Site-directed Mutagenesis Service Product and Solutions
2.4.4 Azenta Life Sciences Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Azenta Life Sciences Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Product and Solutions
2.5.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Bon Opus Biosciences
2.6.1 Bon Opus Biosciences Details
2.6.2 Bon Opus Biosciences Major Business
2.6.3 Bon Opus Biosciences Site-directed Mutagenesis Service Product and Solutions
2.6.4 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bon Opus Biosciences Recent Developments and Future Plans
2.7 Charles Rive
2.7.1 Charles Rive Details
2.7.2 Charles Rive Major Business
2.7.3 Charles Rive Site-directed Mutagenesis Service Product and Solutions
2.7.4 Charles Rive Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Charles Rive Recent Developments and Future Plans
2.8 Creative Biogene
2.8.1 Creative Biogene Details
2.8.2 Creative Biogene Major Business
2.8.3 Creative Biogene Site-directed Mutagenesis Service Product and Solutions
2.8.4 Creative Biogene Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Creative Biogene Recent Developments and Future Plans
2.9 Synbio Technologies
2.9.1 Synbio Technologies Details
2.9.2 Synbio Technologies Major Business
2.9.3 Synbio Technologies Site-directed Mutagenesis Service Product and Solutions
2.9.4 Synbio Technologies Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Synbio Technologies Recent Developments and Future Plans
2.10 Creative Biolabs
2.10.1 Creative Biolabs Details
2.10.2 Creative Biolabs Major Business
2.10.3 Creative Biolabs Site-directed Mutagenesis Service Product and Solutions
2.10.4 Creative Biolabs Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Creative Biolabs Recent Developments and Future Plans
2.11 NovoPro
2.11.1 NovoPro Details
2.11.2 NovoPro Major Business
2.11.3 NovoPro Site-directed Mutagenesis Service Product and Solutions
2.11.4 NovoPro Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 NovoPro Recent Developments and Future Plans
2.12 Bionexus
2.12.1 Bionexus Details
2.12.2 Bionexus Major Business
2.12.3 Bionexus Site-directed Mutagenesis Service Product and Solutions
2.12.4 Bionexus Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bionexus Recent Developments and Future Plans
2.13 Biotech Desk
2.13.1 Biotech Desk Details
2.13.2 Biotech Desk Major Business
2.13.3 Biotech Desk Site-directed Mutagenesis Service Product and Solutions
2.13.4 Biotech Desk Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biotech Desk Recent Developments and Future Plans
2.14 NorClone
2.14.1 NorClone Details
2.14.2 NorClone Major Business
2.14.3 NorClone Site-directed Mutagenesis Service Product and Solutions
2.14.4 NorClone Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 NorClone Recent Developments and Future Plans
2.15 Eton Bioscience
2.15.1 Eton Bioscience Details
2.15.2 Eton Bioscience Major Business
2.15.3 Eton Bioscience Site-directed Mutagenesis Service Product and Solutions
2.15.4 Eton Bioscience Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Eton Bioscience Recent Developments and Future Plans
2.16 Syd Labs
2.16.1 Syd Labs Details
2.16.2 Syd Labs Major Business
2.16.3 Syd Labs Site-directed Mutagenesis Service Product and Solutions
2.16.4 Syd Labs Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Syd Labs Recent Developments and Future Plans
2.17 Genosphere Biotechnologies
2.17.1 Genosphere Biotechnologies Details
2.17.2 Genosphere Biotechnologies Major Business
2.17.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Product and Solutions
2.17.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Genosphere Biotechnologies Recent Developments and Future Plans
2.18 WZ Biosciences
2.18.1 WZ Biosciences Details
2.18.2 WZ Biosciences Major Business
2.18.3 WZ Biosciences Site-directed Mutagenesis Service Product and Solutions
2.18.4 WZ Biosciences Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 WZ Biosciences Recent Developments and Future Plans
2.19 FulenGen
2.19.1 FulenGen Details
2.19.2 FulenGen Major Business
2.19.3 FulenGen Site-directed Mutagenesis Service Product and Solutions
2.19.4 FulenGen Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 FulenGen Recent Developments and Future Plans
2.20 GENEWIZ
2.20.1 GENEWIZ Details
2.20.2 GENEWIZ Major Business
2.20.3 GENEWIZ Site-directed Mutagenesis Service Product and Solutions
2.20.4 GENEWIZ Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 GENEWIZ Recent Developments and Future Plans
2.21 iGene Biotechnology
2.21.1 iGene Biotechnology Details
2.21.2 iGene Biotechnology Major Business
2.21.3 iGene Biotechnology Site-directed Mutagenesis Service Product and Solutions
2.21.4 iGene Biotechnology Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 iGene Biotechnology Recent Developments and Future Plans
2.22 Tsingke
2.22.1 Tsingke Details
2.22.2 Tsingke Major Business
2.22.3 Tsingke Site-directed Mutagenesis Service Product and Solutions
2.22.4 Tsingke Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Tsingke Recent Developments and Future Plans
2.23 AtaGenix
2.23.1 AtaGenix Details
2.23.2 AtaGenix Major Business
2.23.3 AtaGenix Site-directed Mutagenesis Service Product and Solutions
2.23.4 AtaGenix Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 AtaGenix Recent Developments and Future Plans
2.24 Zoonbio Biotechnology
2.24.1 Zoonbio Biotechnology Details
2.24.2 Zoonbio Biotechnology Major Business
2.24.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Product and Solutions
2.24.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Zoonbio Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Site-directed Mutagenesis Service Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Site-directed Mutagenesis Service by Company Revenue
3.2.2 Top 3 Site-directed Mutagenesis Service Players Market Share in 2022
3.2.3 Top 6 Site-directed Mutagenesis Service Players Market Share in 2022
3.3 Site-directed Mutagenesis Service Market: Overall Company Footprint Analysis
3.3.1 Site-directed Mutagenesis Service Market: Region Footprint
3.3.2 Site-directed Mutagenesis Service Market: Company Product Type Footprint
3.3.3 Site-directed Mutagenesis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Site-directed Mutagenesis Service Consumption Value and Market Share by Type (2018-2023)
4.2 Global Site-directed Mutagenesis Service Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2023)
5.2 Global Site-directed Mutagenesis Service Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
6.2 North America Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
6.3 North America Site-directed Mutagenesis Service Market Size by Country
6.3.1 North America Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
6.3.2 United States Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
6.3.3 Canada Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
6.3.4 Mexico Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
7.2 Europe Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
7.3 Europe Site-directed Mutagenesis Service Market Size by Country
7.3.1 Europe Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
7.3.2 Germany Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.3 France Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.5 Russia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.6 Italy Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Site-directed Mutagenesis Service Market Size by Region
8.3.1 Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Region (2018-2029)
8.3.2 China Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.3 Japan Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.4 South Korea Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.5 India Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.7 Australia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
9.2 South America Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
9.3 South America Site-directed Mutagenesis Service Market Size by Country
9.3.1 South America Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
9.3.2 Brazil Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
9.3.3 Argentina Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country
10.3.1 Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
10.3.2 Turkey Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
10.3.4 UAE Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Site-directed Mutagenesis Service Market Drivers
11.2 Site-directed Mutagenesis Service Market Restraints
11.3 Site-directed Mutagenesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Site-directed Mutagenesis Service Industry Chain
12.2 Site-directed Mutagenesis Service Upstream Analysis
12.3 Site-directed Mutagenesis Service Midstream Analysis
12.4 Site-directed Mutagenesis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Site-directed Mutagenesis Service
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Site-directed Mutagenesis Service by Type
1.3.1 Overview: Global Site-directed Mutagenesis Service Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Site-directed Mutagenesis Service Consumption Value Market Share by Type in 2022
1.3.3 Standard Site-directed Mutagenesis Service
1.3.4 Customized Site-directed Mutagenesis Service
1.4 Global Site-directed Mutagenesis Service Market by Application
1.4.1 Overview: Global Site-directed Mutagenesis Service Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Scientific Research
1.4.3 Gene Therapy
1.4.4 Cell Therapy
1.4.5 Others
1.5 Global Site-directed Mutagenesis Service Market Size & Forecast
1.6 Global Site-directed Mutagenesis Service Market Size and Forecast by Region
1.6.1 Global Site-directed Mutagenesis Service Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Site-directed Mutagenesis Service Market Size by Region, (2018-2029)
1.6.3 North America Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.4 Europe Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.6 South America Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Site-directed Mutagenesis Service Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 GenScript
2.1.1 GenScript Details
2.1.2 GenScript Major Business
2.1.3 GenScript Site-directed Mutagenesis Service Product and Solutions
2.1.4 GenScript Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 GenScript Recent Developments and Future Plans
2.2 Eurofins
2.2.1 Eurofins Details
2.2.2 Eurofins Major Business
2.2.3 Eurofins Site-directed Mutagenesis Service Product and Solutions
2.2.4 Eurofins Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eurofins Recent Developments and Future Plans
2.3 Applied Biological Materials
2.3.1 Applied Biological Materials Details
2.3.2 Applied Biological Materials Major Business
2.3.3 Applied Biological Materials Site-directed Mutagenesis Service Product and Solutions
2.3.4 Applied Biological Materials Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Applied Biological Materials Recent Developments and Future Plans
2.4 Azenta Life Sciences
2.4.1 Azenta Life Sciences Details
2.4.2 Azenta Life Sciences Major Business
2.4.3 Azenta Life Sciences Site-directed Mutagenesis Service Product and Solutions
2.4.4 Azenta Life Sciences Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Azenta Life Sciences Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
2.5.1 Thermo Fisher Scientific Details
2.5.2 Thermo Fisher Scientific Major Business
2.5.3 Thermo Fisher Scientific Site-directed Mutagenesis Service Product and Solutions
2.5.4 Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Bon Opus Biosciences
2.6.1 Bon Opus Biosciences Details
2.6.2 Bon Opus Biosciences Major Business
2.6.3 Bon Opus Biosciences Site-directed Mutagenesis Service Product and Solutions
2.6.4 Bon Opus Biosciences Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bon Opus Biosciences Recent Developments and Future Plans
2.7 Charles Rive
2.7.1 Charles Rive Details
2.7.2 Charles Rive Major Business
2.7.3 Charles Rive Site-directed Mutagenesis Service Product and Solutions
2.7.4 Charles Rive Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Charles Rive Recent Developments and Future Plans
2.8 Creative Biogene
2.8.1 Creative Biogene Details
2.8.2 Creative Biogene Major Business
2.8.3 Creative Biogene Site-directed Mutagenesis Service Product and Solutions
2.8.4 Creative Biogene Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Creative Biogene Recent Developments and Future Plans
2.9 Synbio Technologies
2.9.1 Synbio Technologies Details
2.9.2 Synbio Technologies Major Business
2.9.3 Synbio Technologies Site-directed Mutagenesis Service Product and Solutions
2.9.4 Synbio Technologies Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Synbio Technologies Recent Developments and Future Plans
2.10 Creative Biolabs
2.10.1 Creative Biolabs Details
2.10.2 Creative Biolabs Major Business
2.10.3 Creative Biolabs Site-directed Mutagenesis Service Product and Solutions
2.10.4 Creative Biolabs Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Creative Biolabs Recent Developments and Future Plans
2.11 NovoPro
2.11.1 NovoPro Details
2.11.2 NovoPro Major Business
2.11.3 NovoPro Site-directed Mutagenesis Service Product and Solutions
2.11.4 NovoPro Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 NovoPro Recent Developments and Future Plans
2.12 Bionexus
2.12.1 Bionexus Details
2.12.2 Bionexus Major Business
2.12.3 Bionexus Site-directed Mutagenesis Service Product and Solutions
2.12.4 Bionexus Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Bionexus Recent Developments and Future Plans
2.13 Biotech Desk
2.13.1 Biotech Desk Details
2.13.2 Biotech Desk Major Business
2.13.3 Biotech Desk Site-directed Mutagenesis Service Product and Solutions
2.13.4 Biotech Desk Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Biotech Desk Recent Developments and Future Plans
2.14 NorClone
2.14.1 NorClone Details
2.14.2 NorClone Major Business
2.14.3 NorClone Site-directed Mutagenesis Service Product and Solutions
2.14.4 NorClone Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 NorClone Recent Developments and Future Plans
2.15 Eton Bioscience
2.15.1 Eton Bioscience Details
2.15.2 Eton Bioscience Major Business
2.15.3 Eton Bioscience Site-directed Mutagenesis Service Product and Solutions
2.15.4 Eton Bioscience Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Eton Bioscience Recent Developments and Future Plans
2.16 Syd Labs
2.16.1 Syd Labs Details
2.16.2 Syd Labs Major Business
2.16.3 Syd Labs Site-directed Mutagenesis Service Product and Solutions
2.16.4 Syd Labs Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Syd Labs Recent Developments and Future Plans
2.17 Genosphere Biotechnologies
2.17.1 Genosphere Biotechnologies Details
2.17.2 Genosphere Biotechnologies Major Business
2.17.3 Genosphere Biotechnologies Site-directed Mutagenesis Service Product and Solutions
2.17.4 Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 Genosphere Biotechnologies Recent Developments and Future Plans
2.18 WZ Biosciences
2.18.1 WZ Biosciences Details
2.18.2 WZ Biosciences Major Business
2.18.3 WZ Biosciences Site-directed Mutagenesis Service Product and Solutions
2.18.4 WZ Biosciences Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 WZ Biosciences Recent Developments and Future Plans
2.19 FulenGen
2.19.1 FulenGen Details
2.19.2 FulenGen Major Business
2.19.3 FulenGen Site-directed Mutagenesis Service Product and Solutions
2.19.4 FulenGen Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 FulenGen Recent Developments and Future Plans
2.20 GENEWIZ
2.20.1 GENEWIZ Details
2.20.2 GENEWIZ Major Business
2.20.3 GENEWIZ Site-directed Mutagenesis Service Product and Solutions
2.20.4 GENEWIZ Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 GENEWIZ Recent Developments and Future Plans
2.21 iGene Biotechnology
2.21.1 iGene Biotechnology Details
2.21.2 iGene Biotechnology Major Business
2.21.3 iGene Biotechnology Site-directed Mutagenesis Service Product and Solutions
2.21.4 iGene Biotechnology Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 iGene Biotechnology Recent Developments and Future Plans
2.22 Tsingke
2.22.1 Tsingke Details
2.22.2 Tsingke Major Business
2.22.3 Tsingke Site-directed Mutagenesis Service Product and Solutions
2.22.4 Tsingke Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Tsingke Recent Developments and Future Plans
2.23 AtaGenix
2.23.1 AtaGenix Details
2.23.2 AtaGenix Major Business
2.23.3 AtaGenix Site-directed Mutagenesis Service Product and Solutions
2.23.4 AtaGenix Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 AtaGenix Recent Developments and Future Plans
2.24 Zoonbio Biotechnology
2.24.1 Zoonbio Biotechnology Details
2.24.2 Zoonbio Biotechnology Major Business
2.24.3 Zoonbio Biotechnology Site-directed Mutagenesis Service Product and Solutions
2.24.4 Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue, Gross Margin and Market Share (2018-2023)
2.24.5 Zoonbio Biotechnology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Site-directed Mutagenesis Service Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Site-directed Mutagenesis Service by Company Revenue
3.2.2 Top 3 Site-directed Mutagenesis Service Players Market Share in 2022
3.2.3 Top 6 Site-directed Mutagenesis Service Players Market Share in 2022
3.3 Site-directed Mutagenesis Service Market: Overall Company Footprint Analysis
3.3.1 Site-directed Mutagenesis Service Market: Region Footprint
3.3.2 Site-directed Mutagenesis Service Market: Company Product Type Footprint
3.3.3 Site-directed Mutagenesis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Site-directed Mutagenesis Service Consumption Value and Market Share by Type (2018-2023)
4.2 Global Site-directed Mutagenesis Service Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2023)
5.2 Global Site-directed Mutagenesis Service Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
6.2 North America Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
6.3 North America Site-directed Mutagenesis Service Market Size by Country
6.3.1 North America Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
6.3.2 United States Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
6.3.3 Canada Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
6.3.4 Mexico Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
7.2 Europe Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
7.3 Europe Site-directed Mutagenesis Service Market Size by Country
7.3.1 Europe Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
7.3.2 Germany Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.3 France Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.5 Russia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
7.3.6 Italy Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Site-directed Mutagenesis Service Market Size by Region
8.3.1 Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Region (2018-2029)
8.3.2 China Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.3 Japan Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.4 South Korea Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.5 India Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
8.3.7 Australia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
9.2 South America Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
9.3 South America Site-directed Mutagenesis Service Market Size by Country
9.3.1 South America Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
9.3.2 Brazil Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
9.3.3 Argentina Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Site-directed Mutagenesis Service Market Size by Country
10.3.1 Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Country (2018-2029)
10.3.2 Turkey Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
10.3.4 UAE Site-directed Mutagenesis Service Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Site-directed Mutagenesis Service Market Drivers
11.2 Site-directed Mutagenesis Service Market Restraints
11.3 Site-directed Mutagenesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Site-directed Mutagenesis Service Industry Chain
12.2 Site-directed Mutagenesis Service Upstream Analysis
12.3 Site-directed Mutagenesis Service Midstream Analysis
12.4 Site-directed Mutagenesis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Site-directed Mutagenesis Service Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Site-directed Mutagenesis Service Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Site-directed Mutagenesis Service Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Site-directed Mutagenesis Service Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GenScript Company Information, Head Office, and Major Competitors
Table 6. GenScript Major Business
Table 7. GenScript Site-directed Mutagenesis Service Product and Solutions
Table 8. GenScript Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GenScript Recent Developments and Future Plans
Table 10. Eurofins Company Information, Head Office, and Major Competitors
Table 11. Eurofins Major Business
Table 12. Eurofins Site-directed Mutagenesis Service Product and Solutions
Table 13. Eurofins Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eurofins Recent Developments and Future Plans
Table 15. Applied Biological Materials Company Information, Head Office, and Major Competitors
Table 16. Applied Biological Materials Major Business
Table 17. Applied Biological Materials Site-directed Mutagenesis Service Product and Solutions
Table 18. Applied Biological Materials Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Applied Biological Materials Recent Developments and Future Plans
Table 20. Azenta Life Sciences Company Information, Head Office, and Major Competitors
Table 21. Azenta Life Sciences Major Business
Table 22. Azenta Life Sciences Site-directed Mutagenesis Service Product and Solutions
Table 23. Azenta Life Sciences Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Azenta Life Sciences Recent Developments and Future Plans
Table 25. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 26. Thermo Fisher Scientific Major Business
Table 27. Thermo Fisher Scientific Site-directed Mutagenesis Service Product and Solutions
Table 28. Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Thermo Fisher Scientific Recent Developments and Future Plans
Table 30. Bon Opus Biosciences Company Information, Head Office, and Major Competitors
Table 31. Bon Opus Biosciences Major Business
Table 32. Bon Opus Biosciences Site-directed Mutagenesis Service Product and Solutions
Table 33. Bon Opus Biosciences Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bon Opus Biosciences Recent Developments and Future Plans
Table 35. Charles Rive Company Information, Head Office, and Major Competitors
Table 36. Charles Rive Major Business
Table 37. Charles Rive Site-directed Mutagenesis Service Product and Solutions
Table 38. Charles Rive Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Charles Rive Recent Developments and Future Plans
Table 40. Creative Biogene Company Information, Head Office, and Major Competitors
Table 41. Creative Biogene Major Business
Table 42. Creative Biogene Site-directed Mutagenesis Service Product and Solutions
Table 43. Creative Biogene Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Creative Biogene Recent Developments and Future Plans
Table 45. Synbio Technologies Company Information, Head Office, and Major Competitors
Table 46. Synbio Technologies Major Business
Table 47. Synbio Technologies Site-directed Mutagenesis Service Product and Solutions
Table 48. Synbio Technologies Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Synbio Technologies Recent Developments and Future Plans
Table 50. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 51. Creative Biolabs Major Business
Table 52. Creative Biolabs Site-directed Mutagenesis Service Product and Solutions
Table 53. Creative Biolabs Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Creative Biolabs Recent Developments and Future Plans
Table 55. NovoPro Company Information, Head Office, and Major Competitors
Table 56. NovoPro Major Business
Table 57. NovoPro Site-directed Mutagenesis Service Product and Solutions
Table 58. NovoPro Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. NovoPro Recent Developments and Future Plans
Table 60. Bionexus Company Information, Head Office, and Major Competitors
Table 61. Bionexus Major Business
Table 62. Bionexus Site-directed Mutagenesis Service Product and Solutions
Table 63. Bionexus Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Bionexus Recent Developments and Future Plans
Table 65. Biotech Desk Company Information, Head Office, and Major Competitors
Table 66. Biotech Desk Major Business
Table 67. Biotech Desk Site-directed Mutagenesis Service Product and Solutions
Table 68. Biotech Desk Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Biotech Desk Recent Developments and Future Plans
Table 70. NorClone Company Information, Head Office, and Major Competitors
Table 71. NorClone Major Business
Table 72. NorClone Site-directed Mutagenesis Service Product and Solutions
Table 73. NorClone Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. NorClone Recent Developments and Future Plans
Table 75. Eton Bioscience Company Information, Head Office, and Major Competitors
Table 76. Eton Bioscience Major Business
Table 77. Eton Bioscience Site-directed Mutagenesis Service Product and Solutions
Table 78. Eton Bioscience Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Eton Bioscience Recent Developments and Future Plans
Table 80. Syd Labs Company Information, Head Office, and Major Competitors
Table 81. Syd Labs Major Business
Table 82. Syd Labs Site-directed Mutagenesis Service Product and Solutions
Table 83. Syd Labs Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Syd Labs Recent Developments and Future Plans
Table 85. Genosphere Biotechnologies Company Information, Head Office, and Major Competitors
Table 86. Genosphere Biotechnologies Major Business
Table 87. Genosphere Biotechnologies Site-directed Mutagenesis Service Product and Solutions
Table 88. Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Genosphere Biotechnologies Recent Developments and Future Plans
Table 90. WZ Biosciences Company Information, Head Office, and Major Competitors
Table 91. WZ Biosciences Major Business
Table 92. WZ Biosciences Site-directed Mutagenesis Service Product and Solutions
Table 93. WZ Biosciences Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. WZ Biosciences Recent Developments and Future Plans
Table 95. FulenGen Company Information, Head Office, and Major Competitors
Table 96. FulenGen Major Business
Table 97. FulenGen Site-directed Mutagenesis Service Product and Solutions
Table 98. FulenGen Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. FulenGen Recent Developments and Future Plans
Table 100. GENEWIZ Company Information, Head Office, and Major Competitors
Table 101. GENEWIZ Major Business
Table 102. GENEWIZ Site-directed Mutagenesis Service Product and Solutions
Table 103. GENEWIZ Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. GENEWIZ Recent Developments and Future Plans
Table 105. iGene Biotechnology Company Information, Head Office, and Major Competitors
Table 106. iGene Biotechnology Major Business
Table 107. iGene Biotechnology Site-directed Mutagenesis Service Product and Solutions
Table 108. iGene Biotechnology Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. iGene Biotechnology Recent Developments and Future Plans
Table 110. Tsingke Company Information, Head Office, and Major Competitors
Table 111. Tsingke Major Business
Table 112. Tsingke Site-directed Mutagenesis Service Product and Solutions
Table 113. Tsingke Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Tsingke Recent Developments and Future Plans
Table 115. AtaGenix Company Information, Head Office, and Major Competitors
Table 116. AtaGenix Major Business
Table 117. AtaGenix Site-directed Mutagenesis Service Product and Solutions
Table 118. AtaGenix Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. AtaGenix Recent Developments and Future Plans
Table 120. Zoonbio Biotechnology Company Information, Head Office, and Major Competitors
Table 121. Zoonbio Biotechnology Major Business
Table 122. Zoonbio Biotechnology Site-directed Mutagenesis Service Product and Solutions
Table 123. Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Zoonbio Biotechnology Recent Developments and Future Plans
Table 125. Global Site-directed Mutagenesis Service Revenue (USD Million) by Players (2018-2023)
Table 126. Global Site-directed Mutagenesis Service Revenue Share by Players (2018-2023)
Table 127. Breakdown of Site-directed Mutagenesis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 128. Market Position of Players in Site-directed Mutagenesis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 129. Head Office of Key Site-directed Mutagenesis Service Players
Table 130. Site-directed Mutagenesis Service Market: Company Product Type Footprint
Table 131. Site-directed Mutagenesis Service Market: Company Product Application Footprint
Table 132. Site-directed Mutagenesis Service New Market Entrants and Barriers to Market Entry
Table 133. Site-directed Mutagenesis Service Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Site-directed Mutagenesis Service Consumption Value (USD Million) by Type (2018-2023)
Table 135. Global Site-directed Mutagenesis Service Consumption Value Share by Type (2018-2023)
Table 136. Global Site-directed Mutagenesis Service Consumption Value Forecast by Type (2024-2029)
Table 137. Global Site-directed Mutagenesis Service Consumption Value by Application (2018-2023)
Table 138. Global Site-directed Mutagenesis Service Consumption Value Forecast by Application (2024-2029)
Table 139. North America Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 140. North America Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 141. North America Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 142. North America Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 143. North America Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 144. North America Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 145. Europe Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Europe Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Europe Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 148. Europe Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 149. Europe Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 152. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 153. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 154. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 155. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Region (2018-2023) & (USD Million)
Table 156. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Region (2024-2029) & (USD Million)
Table 157. South America Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 158. South America Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 159. South America Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 160. South America Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 161. South America Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 162. South America Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 164. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 165. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 166. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 167. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 168. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 169. Site-directed Mutagenesis Service Raw Material
Table 170. Key Suppliers of Site-directed Mutagenesis Service Raw Materials
Table 1. Global Site-directed Mutagenesis Service Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Site-directed Mutagenesis Service Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Site-directed Mutagenesis Service Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Site-directed Mutagenesis Service Consumption Value by Region (2024-2029) & (USD Million)
Table 5. GenScript Company Information, Head Office, and Major Competitors
Table 6. GenScript Major Business
Table 7. GenScript Site-directed Mutagenesis Service Product and Solutions
Table 8. GenScript Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. GenScript Recent Developments and Future Plans
Table 10. Eurofins Company Information, Head Office, and Major Competitors
Table 11. Eurofins Major Business
Table 12. Eurofins Site-directed Mutagenesis Service Product and Solutions
Table 13. Eurofins Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eurofins Recent Developments and Future Plans
Table 15. Applied Biological Materials Company Information, Head Office, and Major Competitors
Table 16. Applied Biological Materials Major Business
Table 17. Applied Biological Materials Site-directed Mutagenesis Service Product and Solutions
Table 18. Applied Biological Materials Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Applied Biological Materials Recent Developments and Future Plans
Table 20. Azenta Life Sciences Company Information, Head Office, and Major Competitors
Table 21. Azenta Life Sciences Major Business
Table 22. Azenta Life Sciences Site-directed Mutagenesis Service Product and Solutions
Table 23. Azenta Life Sciences Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Azenta Life Sciences Recent Developments and Future Plans
Table 25. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 26. Thermo Fisher Scientific Major Business
Table 27. Thermo Fisher Scientific Site-directed Mutagenesis Service Product and Solutions
Table 28. Thermo Fisher Scientific Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Thermo Fisher Scientific Recent Developments and Future Plans
Table 30. Bon Opus Biosciences Company Information, Head Office, and Major Competitors
Table 31. Bon Opus Biosciences Major Business
Table 32. Bon Opus Biosciences Site-directed Mutagenesis Service Product and Solutions
Table 33. Bon Opus Biosciences Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bon Opus Biosciences Recent Developments and Future Plans
Table 35. Charles Rive Company Information, Head Office, and Major Competitors
Table 36. Charles Rive Major Business
Table 37. Charles Rive Site-directed Mutagenesis Service Product and Solutions
Table 38. Charles Rive Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Charles Rive Recent Developments and Future Plans
Table 40. Creative Biogene Company Information, Head Office, and Major Competitors
Table 41. Creative Biogene Major Business
Table 42. Creative Biogene Site-directed Mutagenesis Service Product and Solutions
Table 43. Creative Biogene Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Creative Biogene Recent Developments and Future Plans
Table 45. Synbio Technologies Company Information, Head Office, and Major Competitors
Table 46. Synbio Technologies Major Business
Table 47. Synbio Technologies Site-directed Mutagenesis Service Product and Solutions
Table 48. Synbio Technologies Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Synbio Technologies Recent Developments and Future Plans
Table 50. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 51. Creative Biolabs Major Business
Table 52. Creative Biolabs Site-directed Mutagenesis Service Product and Solutions
Table 53. Creative Biolabs Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Creative Biolabs Recent Developments and Future Plans
Table 55. NovoPro Company Information, Head Office, and Major Competitors
Table 56. NovoPro Major Business
Table 57. NovoPro Site-directed Mutagenesis Service Product and Solutions
Table 58. NovoPro Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. NovoPro Recent Developments and Future Plans
Table 60. Bionexus Company Information, Head Office, and Major Competitors
Table 61. Bionexus Major Business
Table 62. Bionexus Site-directed Mutagenesis Service Product and Solutions
Table 63. Bionexus Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Bionexus Recent Developments and Future Plans
Table 65. Biotech Desk Company Information, Head Office, and Major Competitors
Table 66. Biotech Desk Major Business
Table 67. Biotech Desk Site-directed Mutagenesis Service Product and Solutions
Table 68. Biotech Desk Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Biotech Desk Recent Developments and Future Plans
Table 70. NorClone Company Information, Head Office, and Major Competitors
Table 71. NorClone Major Business
Table 72. NorClone Site-directed Mutagenesis Service Product and Solutions
Table 73. NorClone Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. NorClone Recent Developments and Future Plans
Table 75. Eton Bioscience Company Information, Head Office, and Major Competitors
Table 76. Eton Bioscience Major Business
Table 77. Eton Bioscience Site-directed Mutagenesis Service Product and Solutions
Table 78. Eton Bioscience Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Eton Bioscience Recent Developments and Future Plans
Table 80. Syd Labs Company Information, Head Office, and Major Competitors
Table 81. Syd Labs Major Business
Table 82. Syd Labs Site-directed Mutagenesis Service Product and Solutions
Table 83. Syd Labs Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Syd Labs Recent Developments and Future Plans
Table 85. Genosphere Biotechnologies Company Information, Head Office, and Major Competitors
Table 86. Genosphere Biotechnologies Major Business
Table 87. Genosphere Biotechnologies Site-directed Mutagenesis Service Product and Solutions
Table 88. Genosphere Biotechnologies Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Genosphere Biotechnologies Recent Developments and Future Plans
Table 90. WZ Biosciences Company Information, Head Office, and Major Competitors
Table 91. WZ Biosciences Major Business
Table 92. WZ Biosciences Site-directed Mutagenesis Service Product and Solutions
Table 93. WZ Biosciences Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. WZ Biosciences Recent Developments and Future Plans
Table 95. FulenGen Company Information, Head Office, and Major Competitors
Table 96. FulenGen Major Business
Table 97. FulenGen Site-directed Mutagenesis Service Product and Solutions
Table 98. FulenGen Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. FulenGen Recent Developments and Future Plans
Table 100. GENEWIZ Company Information, Head Office, and Major Competitors
Table 101. GENEWIZ Major Business
Table 102. GENEWIZ Site-directed Mutagenesis Service Product and Solutions
Table 103. GENEWIZ Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. GENEWIZ Recent Developments and Future Plans
Table 105. iGene Biotechnology Company Information, Head Office, and Major Competitors
Table 106. iGene Biotechnology Major Business
Table 107. iGene Biotechnology Site-directed Mutagenesis Service Product and Solutions
Table 108. iGene Biotechnology Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. iGene Biotechnology Recent Developments and Future Plans
Table 110. Tsingke Company Information, Head Office, and Major Competitors
Table 111. Tsingke Major Business
Table 112. Tsingke Site-directed Mutagenesis Service Product and Solutions
Table 113. Tsingke Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Tsingke Recent Developments and Future Plans
Table 115. AtaGenix Company Information, Head Office, and Major Competitors
Table 116. AtaGenix Major Business
Table 117. AtaGenix Site-directed Mutagenesis Service Product and Solutions
Table 118. AtaGenix Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. AtaGenix Recent Developments and Future Plans
Table 120. Zoonbio Biotechnology Company Information, Head Office, and Major Competitors
Table 121. Zoonbio Biotechnology Major Business
Table 122. Zoonbio Biotechnology Site-directed Mutagenesis Service Product and Solutions
Table 123. Zoonbio Biotechnology Site-directed Mutagenesis Service Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 124. Zoonbio Biotechnology Recent Developments and Future Plans
Table 125. Global Site-directed Mutagenesis Service Revenue (USD Million) by Players (2018-2023)
Table 126. Global Site-directed Mutagenesis Service Revenue Share by Players (2018-2023)
Table 127. Breakdown of Site-directed Mutagenesis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 128. Market Position of Players in Site-directed Mutagenesis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 129. Head Office of Key Site-directed Mutagenesis Service Players
Table 130. Site-directed Mutagenesis Service Market: Company Product Type Footprint
Table 131. Site-directed Mutagenesis Service Market: Company Product Application Footprint
Table 132. Site-directed Mutagenesis Service New Market Entrants and Barriers to Market Entry
Table 133. Site-directed Mutagenesis Service Mergers, Acquisition, Agreements, and Collaborations
Table 134. Global Site-directed Mutagenesis Service Consumption Value (USD Million) by Type (2018-2023)
Table 135. Global Site-directed Mutagenesis Service Consumption Value Share by Type (2018-2023)
Table 136. Global Site-directed Mutagenesis Service Consumption Value Forecast by Type (2024-2029)
Table 137. Global Site-directed Mutagenesis Service Consumption Value by Application (2018-2023)
Table 138. Global Site-directed Mutagenesis Service Consumption Value Forecast by Application (2024-2029)
Table 139. North America Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 140. North America Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 141. North America Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 142. North America Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 143. North America Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 144. North America Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 145. Europe Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 146. Europe Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 147. Europe Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 148. Europe Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 149. Europe Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 150. Europe Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 151. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 152. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 153. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 154. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 155. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Region (2018-2023) & (USD Million)
Table 156. Asia-Pacific Site-directed Mutagenesis Service Consumption Value by Region (2024-2029) & (USD Million)
Table 157. South America Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 158. South America Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 159. South America Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 160. South America Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 161. South America Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 162. South America Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 163. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Type (2018-2023) & (USD Million)
Table 164. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Type (2024-2029) & (USD Million)
Table 165. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Application (2018-2023) & (USD Million)
Table 166. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Application (2024-2029) & (USD Million)
Table 167. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Country (2018-2023) & (USD Million)
Table 168. Middle East & Africa Site-directed Mutagenesis Service Consumption Value by Country (2024-2029) & (USD Million)
Table 169. Site-directed Mutagenesis Service Raw Material
Table 170. Key Suppliers of Site-directed Mutagenesis Service Raw Materials
LIST OF FIGURES
Figure 1. Site-directed Mutagenesis Service Picture
Figure 2. Global Site-directed Mutagenesis Service Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Site-directed Mutagenesis Service Consumption Value Market Share by Type in 2022
Figure 4. Standard Site-directed Mutagenesis Service
Figure 5. Customized Site-directed Mutagenesis Service
Figure 6. Global Site-directed Mutagenesis Service Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Site-directed Mutagenesis Service Consumption Value Market Share by Application in 2022
Figure 8. Scientific Research Picture
Figure 9. Gene Therapy Picture
Figure 10. Cell Therapy Picture
Figure 11. Others Picture
Figure 12. Global Site-directed Mutagenesis Service Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Site-directed Mutagenesis Service Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Site-directed Mutagenesis Service Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Site-directed Mutagenesis Service Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Site-directed Mutagenesis Service Consumption Value Market Share by Region in 2022
Figure 17. North America Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Site-directed Mutagenesis Service Revenue Share by Players in 2022
Figure 23. Site-directed Mutagenesis Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Site-directed Mutagenesis Service Market Share in 2022
Figure 25. Global Top 6 Players Site-directed Mutagenesis Service Market Share in 2022
Figure 26. Global Site-directed Mutagenesis Service Consumption Value Share by Type (2018-2023)
Figure 27. Global Site-directed Mutagenesis Service Market Share Forecast by Type (2024-2029)
Figure 28. Global Site-directed Mutagenesis Service Consumption Value Share by Application (2018-2023)
Figure 29. Global Site-directed Mutagenesis Service Market Share Forecast by Application (2024-2029)
Figure 30. North America Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 40. France Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Site-directed Mutagenesis Service Consumption Value Market Share by Region (2018-2029)
Figure 47. China Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 50. India Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 64. Site-directed Mutagenesis Service Market Drivers
Figure 65. Site-directed Mutagenesis Service Market Restraints
Figure 66. Site-directed Mutagenesis Service Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Site-directed Mutagenesis Service in 2022
Figure 69. Manufacturing Process Analysis of Site-directed Mutagenesis Service
Figure 70. Site-directed Mutagenesis Service Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Site-directed Mutagenesis Service Picture
Figure 2. Global Site-directed Mutagenesis Service Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Site-directed Mutagenesis Service Consumption Value Market Share by Type in 2022
Figure 4. Standard Site-directed Mutagenesis Service
Figure 5. Customized Site-directed Mutagenesis Service
Figure 6. Global Site-directed Mutagenesis Service Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Site-directed Mutagenesis Service Consumption Value Market Share by Application in 2022
Figure 8. Scientific Research Picture
Figure 9. Gene Therapy Picture
Figure 10. Cell Therapy Picture
Figure 11. Others Picture
Figure 12. Global Site-directed Mutagenesis Service Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Site-directed Mutagenesis Service Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Site-directed Mutagenesis Service Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Site-directed Mutagenesis Service Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Site-directed Mutagenesis Service Consumption Value Market Share by Region in 2022
Figure 17. North America Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Site-directed Mutagenesis Service Revenue Share by Players in 2022
Figure 23. Site-directed Mutagenesis Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Site-directed Mutagenesis Service Market Share in 2022
Figure 25. Global Top 6 Players Site-directed Mutagenesis Service Market Share in 2022
Figure 26. Global Site-directed Mutagenesis Service Consumption Value Share by Type (2018-2023)
Figure 27. Global Site-directed Mutagenesis Service Market Share Forecast by Type (2024-2029)
Figure 28. Global Site-directed Mutagenesis Service Consumption Value Share by Application (2018-2023)
Figure 29. Global Site-directed Mutagenesis Service Market Share Forecast by Application (2024-2029)
Figure 30. North America Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 40. France Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Site-directed Mutagenesis Service Consumption Value Market Share by Region (2018-2029)
Figure 47. China Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 50. India Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Site-directed Mutagenesis Service Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Site-directed Mutagenesis Service Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Site-directed Mutagenesis Service Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Site-directed Mutagenesis Service Consumption Value (2018-2029) & (USD Million)
Figure 64. Site-directed Mutagenesis Service Market Drivers
Figure 65. Site-directed Mutagenesis Service Market Restraints
Figure 66. Site-directed Mutagenesis Service Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Site-directed Mutagenesis Service in 2022
Figure 69. Manufacturing Process Analysis of Site-directed Mutagenesis Service
Figure 70. Site-directed Mutagenesis Service Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
